Loading clinical trials...
Loading clinical trials...
Randomized Pilot Trial of Chemoradiation Plus or Minus Amifostine to Assess Potential Nutritional, Inflammatory and Physical Outcomes Related to Xerostomia, Mucositis and Dysphagia
Conditions
Interventions
exercise intervention
amifostine trihydrate
+1 more
Locations
1
United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Start Date
January 1, 2006
Primary Completion Date
August 1, 2008
Completion Date
August 1, 2008
Last Updated
June 20, 2017
NCT05853692
NCT04585750
NCT07457346
NCT06636188
NCT05526924
NCT07065630
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions